February 20, 2025 - 23:58

ACU-Serve, a prominent player in healthcare revenue cycle optimization solutions, has officially welcomed Grant Porteous as its new Chief Technology Officer. Porteous brings a wealth of experience in technology leadership, having held various senior roles in the industry over the past two decades. His expertise lies in driving innovation and leveraging technology to enhance operational efficiency.
In his new role, Porteous will be responsible for overseeing the development and implementation of cutting-edge technology solutions that aim to improve the revenue cycle processes for healthcare providers. His strategic vision is expected to play a crucial role in advancing ACU-Serve's mission to deliver exceptional service and value to its clients.
Porteous expressed enthusiasm about joining ACU-Serve, highlighting the company's commitment to excellence and its focus on customer satisfaction. He is eager to collaborate with the talented team at ACU-Serve to drive technological advancements that will ultimately benefit healthcare organizations and their patients.
August 8, 2026 - 01:15
19th century real estate agents used ‘peepshow’ technology to sell glitzy mansionBefore Zillow, before glossy real estate brochures, there was the cosmorama. In the 1840s, wealthy home sellers and developers in Europe and America turned to these handheld viewing boxes to show...
August 7, 2026 - 06:56
AI used to create viruses not found in nature for first timeA team of researchers in the United States has announced the creation of 16 new viruses that do not exist in nature, marking the first time artificial intelligence has been used to design such...
August 6, 2026 - 19:49
MatSing Details Manufacturing Technology to Improve Satellite Antenna PerformanceMatSing has introduced a proprietary manufacturing process designed to boost the capabilities of multibeam and wideband antennas used in satellite communications. The company says the new technique...
August 6, 2026 - 03:31
FDA approves Moderna’s mRNA flu vaccine, the first to use the technologyThe U.S. Food and Drug Administration has given the green light to Moderna`s new influenza vaccine, marking the first time a flu shot built on messenger RNA technology has been licensed. The...